BLAIR WILLIAM & CO/IL - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$313,304
-37.4%
11,660
-17.0%
0.00%
-50.0%
Q2 2023$500,666
+36.0%
14,040
-3.1%
0.00%
+100.0%
Q1 2023$368,046
-39.7%
14,490
-3.8%
0.00%
-66.7%
Q4 2022$610,793
+9.1%
15,059
-11.0%
0.00%0.0%
Q3 2022$560,000
-20.2%
16,929
-15.1%
0.00%0.0%
Q2 2022$702,000
-24.8%
19,934
-1.9%
0.00%0.0%
Q1 2022$934,000
-31.7%
20,319
-1.5%
0.00%
-25.0%
Q4 2021$1,367,000
+5.8%
20,619
-0.4%
0.00%0.0%
Q3 2021$1,292,000
-25.4%
20,702
-1.0%
0.00%
-33.3%
Q2 2021$1,732,000
+23.1%
20,914
-1.4%
0.01%
+20.0%
Q1 2021$1,407,000
-17.2%
21,218
-4.2%
0.01%
-16.7%
Q4 2020$1,699,000
+69.4%
22,140
-4.9%
0.01%
+50.0%
Q3 2020$1,003,000
+3.0%
23,290
+3.3%
0.00%
-20.0%
Q2 2020$974,000
+43.4%
22,540
-4.5%
0.01%
+25.0%
Q1 2020$679,000
-77.2%
23,590
-49.8%
0.00%
-73.3%
Q4 2019$2,982,000
+174.8%
47,013
+22.0%
0.02%
+150.0%
Q3 2019$1,085,000
+4.7%
38,520
-1.5%
0.01%0.0%
Q2 2019$1,036,000
+43.1%
39,100
-0.9%
0.01%
+50.0%
Q1 2019$724,000
-10.7%
39,450
-39.6%
0.00%
-33.3%
Q4 2018$811,000
-37.4%
65,325
-3.3%
0.01%
-25.0%
Q3 2018$1,296,000
+50.9%
67,580
+7.0%
0.01%
+33.3%
Q2 2018$859,000
+28.4%
63,170
-32.0%
0.01%
+20.0%
Q1 2018$669,00092,8500.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders